174 related articles for article (PubMed ID: 9204005)
1. Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review.
Cheng K; Ashby D; Smyth R
J R Soc Med; 1997; 90 Suppl 31(Suppl 31):6-12. PubMed ID: 9204005
[No Abstract] [Full Text] [Related]
2. Cystic fibrosis-associated liver disease.
Herrmann U; Dockter G; Lammert F
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):585-92. PubMed ID: 20955961
[TBL] [Abstract][Full Text] [Related]
3. [Hepatobiliary disease in cystic fibrosis].
Pérez-Aguilar F; Berenguer Lapuerta J
Med Clin (Barc); 1998 Sep; 111(8):302-6. PubMed ID: 9810550
[No Abstract] [Full Text] [Related]
4. Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Cheng K; Ashby D; Smyth RL
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD000222. PubMed ID: 28891588
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Cheng K; Ashby D; Smyth RL
Cochrane Database Syst Rev; 2014 Dec; (12):CD000222. PubMed ID: 25501301
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Cheng K; Ashby D; Smyth R
Cochrane Database Syst Rev; 2000; (2):CD000222. PubMed ID: 10796703
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Cheng K; Ashby D; Smyth RL
Cochrane Database Syst Rev; 2012 Oct; 10():CD000222. PubMed ID: 23076885
[TBL] [Abstract][Full Text] [Related]
8. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease.
Siano M; De Gregorio F; Boggia B; Sepe A; Ferri P; Buonpensiero P; Di Pasqua A; Raia V
Dig Liver Dis; 2010 Jun; 42(6):428-31. PubMed ID: 20034860
[TBL] [Abstract][Full Text] [Related]
10. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
Lebensztejn DM
Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
[TBL] [Abstract][Full Text] [Related]
11. The effect of ursodeoxycholic acid in cystic cholangiopathies.
Lammert F; Méndez-Sánchez N
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):949-950. PubMed ID: 27740534
[No Abstract] [Full Text] [Related]
12. Hepatic Manifestations of Cystic Fibrosis.
Sakiani S; Kleiner DE; Heller T; Koh C
Clin Liver Dis; 2019 May; 23(2):263-277. PubMed ID: 30947876
[TBL] [Abstract][Full Text] [Related]
13. Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease.
Colombo C; Crosignani A; Battezzati PM; Castellani MR; Comi S; Melzi ML; Giunta A
J Hepatol; 1999 Oct; 31(4):672-7. PubMed ID: 10551391
[TBL] [Abstract][Full Text] [Related]
14. Use of ursodeoxycholic acid in liver diseases.
Kumar D; Tandon RK
J Gastroenterol Hepatol; 2001 Jan; 16(1):3-14. PubMed ID: 11206313
[TBL] [Abstract][Full Text] [Related]
15. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.
Alenezi B; Lamoureux E; Alpert L; Szilagyi A
Dig Dis Sci; 2005 Jan; 50(1):196-200. PubMed ID: 15712660
[No Abstract] [Full Text] [Related]
16. Oral bile acids in cystic fibrosis-associated liver disease.
Colombo C; Crosignani A; Apostolo MG; Marzano MT; Bettinardi N; Giunta A
J R Soc Med; 1994; 87 Suppl 21(Suppl 21):20-4. PubMed ID: 8201582
[No Abstract] [Full Text] [Related]
17. Pancreatic Cystosis and Intrahepatic Biliopathy in a Young Adult with Cystic Fibrosis.
Al Qatarneh S; Michel HK; Lindblad D; Ozolek J; Venkat V; Weiner DJ
J Pediatr; 2018 Dec; 203():457-457.e1. PubMed ID: 30041939
[No Abstract] [Full Text] [Related]
18. Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease.
Nousia-Arvanitakis S; Fotoulaki M; Economou H; Xefteri M; Galli-Tsinopoulou A
J Clin Gastroenterol; 2001 Apr; 32(4):324-8. PubMed ID: 11276276
[TBL] [Abstract][Full Text] [Related]
19. [The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system].
Dehtiar'ova II; Chernenko VV; Anokhina HA; Opanasiuk ND; Pavlik-Novol's'kyĭ T; Haĭsenko AV
Lik Sprava; 1995; (9-12):47-8. PubMed ID: 8983789
[No Abstract] [Full Text] [Related]
20. Ursodeoxycholic acid therapy in hepatobiliary disease.
Kowdley KV
Am J Med; 2000 Apr; 108(6):481-6. PubMed ID: 10781781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
